Mitral Valve Replacement (Surgical)
Treatment for Non-rheumatic degenerative mitral valve disease
Effectiveness
88%
Safety Score
50%
Clinical Trials
1,200
Participants
400K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
50
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate symptom relief post-recovery (full recovery 3-6 months)
Treatment Duration
One-time procedure (lifelong anticoagulation for mechanical valve)
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,000
Monitoring:$1,500
Side Effect Mgmt:$750
Total Annual:$3,250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$45,000/QALY
QALYs Gained
4
Outcome-Based Costs
Cost per Responder
$3,421.05
Cost per Remission
$3,611.11
Comparison vs Mitral Valve Repair
Cost Difference
+$10,000/year
More expensive
QALY Difference
-0.50 QALYs
Worse outcomes
Dominance
No dominance
Mitral Valve Replacement (Surgical) Outcomes
for Non-rheumatic degenerative mitral valve disease
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Arrhythmias (e.g., Atrial Fibrillation)
+28%
Bleeding/Transfusion
+10%
Stroke
+2.5%
Infection
+3%
Acute Kidney Injury
+7%
In-hospital Mortality
+3.5%
Anticoagulation-related bleeding (with mechanical valve)
+2.5%
Bioprosthetic valve degeneration/re-operation
+15%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov